Centogene N.V. (CNTG)
| Previous close | 2.7200 |
| Open | 2.7149 |
| Bid | 2.6900 x 3000 |
| Ask | 2.8500 x 1100 |
| Day's range | 2.6900 - 2.7149 |
| 52-week range | 2.6900 - 11.9500 |
| Volume | |
| Avg. volume | 11,527 |
| Market cap | 72.849M |
| Beta (5Y monthly) | -1.21 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
CENTOGENE’s CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms Compliant With European IVD Regulatory Framework
CE-marked clinical decision support platform enables laboratories to provide best-in-class diagnostics of genetic diseasesCentoCloud, CENTOGENE’s cloud-based Software as a Service (SaaS) platform, is CE-marked under the In Vitro Diagnostics Directive (98/79/EC)CE-marking is required for all in vitro diagnostic (IVD) devices to be placed in the European Economic Area (EEA) countries, as well as Iceland, Norway, and Liechtenstein, and indicates that the device may be legally commercialized in this
- GlobeNewswire
CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequencing (WGS) in Rare Disease Diagnostics
Newly established WGS recommendations published in the European Journal of Human Genetics Collaborative initiative leverages CENTOGENE’s differentiated diagnostic expertise with testing performed in over 650,000 individuals globallyRecommendations provide standardized clinical application guidelines for laboratories to accelerate comprehensive diagnosis and promote better health outcomesWGS increasingly popular for high-quality diagnostics, with the number of CENTOGENE WGS tests increasing doubl
- GlobeNewswire
CENTOGENE to Present at the H.C. Wainwright Global Investment Conference
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 19, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced that Company management will present in the virtual track at the H.C. Wainwright Global Investment Conference being held May 23–26, 2022, and invites investors to participate via virtual one-on-one meetings. Please see additional details below: H.C. Wainwright Global I
